Low maternal vitamin D as a risk factor for schizophrenia: A pilot study using banked sera

Schizophrenia Research

Volumn 63, Issue 1-2, 2003, Pages 73-78

  McGrath, John ^a   Eyles, Darryl ^a   Mowry, Bryan ^a   Yolken, Robert ^b   Buka, Stephen ^c,d,e  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e Harvard Inst Psychiat E   (United States)

Author keywords

Banked sera; Schizophrenia; Vitamin D

Indexed keywords

BIOLOGICAL MARKER; CALCIFEDIOL; VITAMIN D;

ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; HUMAN; MALE; MOTHER; NEWBORN; NUTRITIONAL DEFICIENCY; PRIORITY JOURNAL; PROGENY; RACE DIFFERENCE; RISK FACTOR; SCHIZOPHRENIA; SERUM; SEX DIFFERENCE; THIRD TRIMESTER PREGNANCY; VITAMIN BLOOD LEVEL;

EID: 0043209108     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(02)00435-8     Document Type: Article

References (41)

1. Abrams S.A. Nutritional rickets: an old disease returns. Nutr. Rev. 60:2002;111-115.
2. Braun M.M., Helzlsouer K.J., Hollis B.W., Comstock G.W. Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States). CCC, Cancer Causes Control. 6:1995;235-239.
3. Breslow, N.E., Day, N.E., 1980. Statistical Methods in Cancer Research, Vol. 1: The Analysis of Case-Control Studies, IARC Scientific Publications No. 32, International Agency of Research on Cancer, Lyon, France.
4. Brown A.S., Susser E.S., Butler P.D., Richardson A.R., Kaufmann C.A., Gorman J.M. Neurobiological plausibility of prenatal nutritional deprivation as a risk factor for schizophrenia. J. of Nerv. Ment. Dis. 184:1996;71-85.
5. Brown A.S., van Os J., Driessens C., Hoek H.W., Susser E.S. Further evidence of relation between prenatal famine and major affective disorder. Am. J. Psychiatry. 157:2000;190-195.
6. Buka S.L., Goldstein J.M., Seidman L.J., Zornberg G.L., Donatelli J.A., Denny L.R., Tsuang M.T. Prenatal complications, genetic vulnerability, and schizophrenia: the New England longitudinal studies of schizophrenia. Psychiatr. Ann. 29:1999;151-156.
7. Buka S.L., Tsuang M.T., Torrey E.F., Klebanoff M.A., Bernstein D., Yolken R.H. Maternal infections and subsequent psychosis among offspring. Arch. Gen. Psychiatry. 58:2001;1032-1037.
8. Corder E.H., Guess H.A., Hulka B.S., Friedman G.D., Sadler M., Vollmer R.T., Lobaugh B., Drezner M.K., Vogelman J.H., Orentreich N. Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol. Biomark. Prev. 2:1993;467-472.
9. DeLuca H.F., Zierold C. Mechanisms and functions of vitamin D. Nutr. Rev. 56:1998;S4-S10. (discussion S 54-75).
10. 3 disrupts foetal brain maturation. Schizophr. Res. 53:2002;228.
11. Feron F., Mackay-Sim A., Eyles D., Brown J., McGrath J. Vitamin D depletion during development markedly alters gene expression in adult rat brain: gene array assessment of a novel risk factor for schizophrenia. Schizophr. Res. 53:2002;83.
12. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV). 1996;American Psychiatric Press, Washington, DC.
13. Gallagher B.J., Jones B.J., McFalls J.A. The "winter born phenomenon" among schizophrenics: differences between Blacks and Whites. J. Clin. Psychol. 40:1984;1151-1159.
14. Garcion E., Wion-Barbot N., Montero-Menei C.N., Berger F., Wion D. New clues about vitamin D functions in the nervous system. Trends Endocrinol. Metab. 13:2002;100-105.
15. Harris S.S., Dawson-Hughes B. Seasonal changes in plasma 25-hydroxyvitamin D concentrations of young American black and white women. Am. J. Clin. Nutr. 67:1998;1232-1236.
16. Harrison G. Searching for the causes of schizophrenia: the role of migrant studies. Schizophr. Bull. 16:1990;663-671.
17. Holick M.F. Environmental factors that influence the cutaneous production of vitamin D. Am. J. Clin. Nutr. 61:1995;638S-645S.
18. Hollis B.W. Comparison of commercially available (125)I-based RIA methods for the determination of circulating 25-hydroxyvitamin D. Clin. Chem. 46:2000;1657-1661.
19. Hunter D. Biochemical indicators of dietary information. Willett W. Nutritional Epidemiology. 1998;174-243 Oxford Univ. Press, New York.
20. Kendler K.S., Gallagher T.J., Abelson J.M., Kessler R.C. Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample. The National Comorbidity Survey. Arch. Gen. Psychiatry. 53:1996;1022-1031.
21. Kreiter S.R., Schwartz R.P., Kirkman H.N. Jr., Charlton P.A., Calikoglu A.S., Davenport M.L. Nutritional rickets in African American breast-fed infants. J. Pediatr. 137:2000;153-157.
22. Looker A.C., Dawson-Hughes B., Calvo M.S., Gunter E.W., Sahyoun N.R. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone. 30:2002;771-777.
23. Mackay-Sim A., Feron F., Eyles D., Brown J., McGrath J. Low vitamin D disrupts prepulse inhibition in adult but not young rats: a new animal model of schizophrenia. Schizophr. Res. 53:2002;216.
24. Marcelis M., Navarro-Mateu F., Murray R., Selten J.-P., van Os J. Urbanization and psychosis: a stud of 1942-1978 birth cohorts in The Netherlands. Psychol. Med. 28:1998;871-879.
25. McGrath J. Hypothesis: is low prenatal vitamin D a risk-modifying factor for schizophrenia? Schizophr. Res. 40:1999;173-177.
26. McGrath J., Feron F., Eyles D. Vitamin D: the neglected neurosteroid? Trends Neurosci. 24:2001;570-572.
27. McGrath J.J., Kimlin M.G., Saha S., Eyles D.W., Parisi A.V. Vitamin D insufficiency in south-east Queensland. Med. J. Aust. 174:2001;150-151.
28. Mortensen P.B., Pedersen C.B., Westergaard T., Wohlfahrt J., Ewald H., Mors O., Andersen P.K., Melbye M. Familial and non-familial risk factors for schizophrenia: a population-based study. Schizophr. Res. 29:1998;13.
29. Moskovitz R.A. Seasonality in schizophrenia. (letter) Lancet. 1:1978;664.
30. Nomura A.M., Stemmermann G.N., Lee J., Kolonel L.N., Chen T.C., Turner A., Holick M.F. Serum vitamin D metabolite levels and the subsequent development of prostate cancer (Hawaii, United States). CCC, Cancer Causes Control. 9:1998;425-432.
31. Pile W.J. A study of the correlation between dementia praecox and the month of birth. Va. Med. Mon. 78:1951;438-440.
32. 3 receptor immunoreactivity in the rat brain and spinal cord. J. Chem. Neuroanat. 16:1999;135-145.
33. Regier D.A., Farmer M.E., Rae D.S., Myers J.K., Kramer M., Robins L.N., George L.K., Karno M., Locke B.Z. One-month prevalence of mental disorders in the United States and sociodemographic characteristics: the Epidemiologic Catchment Area study. Acta Psychiatr. Scand. 88:1993;35-47.
34. Selten J.P., Veen N., Feller W., Blom J.D., Schols D., Camoenie W., Oolders J., van der Velden M., Hoek H.W., Rivero V.M., van der Graaf Y., Kahn R. Incidence of psychotic disorders in immigrant groups to The Netherlands. Br. J. Psychiatry. 178:2001;367-372.
35. Susser E.S., Lin S.P. Schizophrenia after prenatal exposure to the Dutch hunger winter of 1944-1945. Arch. Gen. Psychiatry. 49:1992;938-988.
36. Susser E., Neugebauer R., Hoek H., Brown A.S., Lin S., Labovitz D., Gorman J.M. Schizophrenia after prenatal famine: further evidence. Arch. Gen. Psychiatry. 53:1996;25-31.
37. Susser E., Hoek H.W., Brown A. Neurodevelopmental disorders after prenatal famine: the story of the Dutch Famine Study. Am. J. Epidemiol. 147:1998;213-216.
38. Sutherland M.K., Somerville M.J., Yoong L.K., Bergeron C., Haussler M.R., McLachlan D.R. Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28 k mRNA levels. Brain Res. Mol. Brain Res. 13:1992;239-250.
39. 3 receptors in the central nervous system of the rat embryo. Brain Res. 804:1998;193-205.
40. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am. J. Clin. Nutr. 69:1999;842-856.
41. Zornberg G.L., Buka S.L., Tsuang M.T. Hypoxic-ischemia-related fetal/neonatal complications and risk of schizophrenia and other nonaffective psychoses: a 19-year longitudinal study. Am. J. Psychiatry. 157:2000;196-202.